SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma

An accurate diagnostic marker for detecting early-stage hepatocellular carcinoma (eHCC) is clinically important, since early detection of HCC remarkably improves patient survival. From the integrative analysis of the transcriptome and clinicopathologic data of human multi-stage HCC tissues, we were...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Qingyu, Nam, Suk Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2018
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836557/
https://www.ncbi.nlm.nih.gov/pubmed/29397868
http://dx.doi.org/10.5483/BMBRep.2018.51.2.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836557/
https://www.ncbi.nlm.nih.gov/pubmed/29397868
http://dx.doi.org/10.5483/BMBRep.2018.51.2.021

Ejemplares similares